Celgene to buy biotechnology company Juno Therapeutics for about $9 billion

Celgene on Monday agreed to buy biotechnology company Juno Therapeutics for about $9 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.